Earnings calendar/BIIB
Biogen Inc. (BIIB)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$2.09
Street estimate
Revenue target
$2.64B
Street estimate
Trailing EPS (avg 4Q)
$3.49
Beat rate last 4: 100%
Latest EPS YoY
-34.2%
vs 2025-07-31
Latest revenue YoY
+3.4%
How results look so far
Trailing revenue (avg 4Q)
$2.49B
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 29, 2026
EPS beat
EPS actual / est
$3.60 / $2.94
+22.4%
Revenue actual / est
$2.74B / $2.46B
+11.2%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $2.09 | Pending | — | $2.64B | Pending | — |
| 7/30/2026upcoming | $3.20 | Pending | — | $2.43B | Pending | — |
| 7/29/2026 | $2.94 | $3.60 | +22.4% | $2.46B | $2.74B | +11.2% |
| 5/7/2026upcoming | $3.03 | Pending | — | $2.25B | Pending | — |
| 4/29/2026 | $3.05 | $3.57 | +17.0% | $2.29B | $2.48B | +8.4% |
| 2/11/2026upcoming | $1.73 | Pending | — | — | Pending | — |
| 2/6/2026 | $1.63 | $1.99 | +22.1% | $2.20B | $2.28B | +3.5% |
| 10/30/2025 | $3.88 | $4.81 | +24.0% | $2.34B | $2.45B | +4.9% |
| 7/31/2025 | $3.90 | $5.47 | +40.3% | $2.33B | $2.65B | +13.6% |
| 5/1/2025 | $2.90 | $3.02 | +4.1% | $2.23B | $2.43B | +8.8% |
| 2/12/2025 | $3.43 | $3.44 | +0.3% | $2.41B | $2.45B | +1.9% |
| 10/30/2024 | $3.77 | $4.08 | +8.2% | $2.43B | $2.47B | +1.3% |
| 8/1/2024 | $4.07 | $5.28 | +29.7% | $2.39B | $2.35B | -1.6% |
| 4/24/2024 | $3.47 | $3.67 | +5.8% | $2.31B | $2.29B | -0.8% |
| 2/13/2024 | $3.16 | $2.95 | -6.6% | $2.47B | $2.39B | -3.2% |
| 11/8/2023 | $3.99 | $4.36 | +9.3% | $2.39B | $2.53B | +5.9% |
| 7/25/2023 | $3.77 | $4.02 | +6.6% | $2.37B | $2.46B | +3.7% |
| 4/25/2023 | $3.28 | $3.40 | +3.7% | $2.34B | $2.46B | +5.2% |
| 2/15/2023 | $3.48 | $4.05 | +16.4% | $2.45B | $2.54B | +4.0% |
| 10/25/2022 | $4.13 | $4.77 | +15.5% | $2.47B | $2.51B | +1.6% |
Need BIIB data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.